4//SEC Filing
Klinger Shannon Thyme 4
Accession 0001682852-25-000080
CIK 0001682852other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:24 PM ET
Size
13.8 KB
Accession
0001682852-25-000080
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Klinger Shannon Thyme
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-26+773→ 28,943 total - Tax Payment
Common Stock
2025-11-26$24.75/sh−374$9,257→ 28,569 total - Exercise/Conversion
Common Stock
2025-11-28+329→ 28,898 total - Tax Payment
Common Stock
2025-11-28$25.01/sh−160$4,002→ 28,738 total - Exercise/Conversion
Restricted Stock Units
2025-11-26−773→ 6,963 total→ Common Stock (773 underlying) - Exercise/Conversion
Restricted Stock Units
2025-11-28−329→ 1,644 total→ Common Stock (329 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- [F3]25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F4]25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001866132
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:24 PM ET
- Size
- 13.8 KB